Health Canada

1087 articles with Health Canada

• Health Canada grants Interim Order authorization for casirivimab and imdevimab for the treatment of mild to moderate COVID-19

  6/10/2021

  Hoffmann-La Roche Limited announced that Health Canada has issued an Interim Order authorization for casirivimab and imdevimab, to be administered together, for the treatment of mild to moderate coronavirus disease 2019, confirmed by direct SARS-CoV-2 viral testing, in adults and adolescents who are at high-risk for progressing to hospitalization and/or death.

• Pulse Biosciences Announces Health Canada Approval for CellFX® System

  6/9/2021

  Pulse Biosciences Announces Health Canada Approval for CellFX ® System - Company to Expand Global Controlled Launch Program with Clinical Aesthetic Experts in Canada.

• Advisory - Be informed: know the potential risks of buying health products online

  6/8/2021

  Many websites that sell health products are lawful businesses, but some sell health products that pose serious health risks.

• Labelling update regarding the use of non-steroidal anti-inflammatory drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage to unborn babies

  6/8/2021

  Health Canada has completed a safety review confirming that the use of non-steroid anti-inflammatory drugs —such as acetylsalicylic acid, ibuprofen, naproxen, diclofenac and celecoxib —starting from approximately 20 weeks of pregnancy or later, may cause rare but serious kidney problems in an unborn baby.

• Oscor launches Breezeway II Transseptal Access Delivery System

  6/8/2021

  Oscor receives CE Mark, FDA, and Health Canada clearance on its Breezeway II next generation transseptal access delivery system.

• Advisory - All lots of Renadyl probiotic capsules recalled due to undeclared ingredient and missing safety warnings on the label

  6/7/2021

  Gelda Scientific and Industrial Development Corporation is recalling all lots of Renadyl probiotic capsules because the product contains undeclared inulin and important safety warnings are missing from the product label.

• Celltrion Healthcare launches Remsima™ SC, the world's first subcutaneous formulation of infliximab in Canada, for the treatment of people with rheumatoid arthritis

  6/7/2021

  Celltrion Healthcare Canada Limited announced the launch of Remsima™ SC, the world's first subcutaneous formulation of infliximab in Canada for the treatment of adult patients with rheumatoid arthritis.

• Advisory - Health Canada warns of Xing da Toy magnet sets that pose serious and potentially life-threatening risks

  6/3/2021

  Health Canada is warning Canadians of the serious danger posed by two magnet sets, Xing da Toy Circular Magnets and Xing da Toy Oval Magnets sold in Canada.

• Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order

  6/2/2021

  COVID-SeroKlir detects both the presence and precise level of neutralizing IgG antibodies with 98.8% sensitivity and 99.6% specificity

• Statement from the Council of Chief Medical Officers of Health (CCMOH): Interchangeability of Authorized COVID-19 Vaccines

  6/2/2021

  Canada's approach to vaccination has enabled individuals in Canada to protect themselves, their families and communities against severe COVID-19 outcomes and reduce the risk of transmission of the virus.

• Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms

  5/25/2021

  Increased cultivation capacity will enhance the Company’s ability to produce pharmaceutical grade psilocybin at scale

• Government of Canada supports safer supply project for people with opioid use disorder in Guelph

  5/20/2021

  Life-saving initiative will provide pharmaceutical-grade medication as alternative to toxic illegal drug supply during COVID-19 pandemic and beyond

• Health Canada authorizes more flexible storage conditions for Pfizer-BioNTech COVID-19 vaccine

  5/19/2021

  Health Canada authorized a submission from Pfizer-BioNTech to allow its COVID-19 vaccine to be stored at regular refrigerated temperatures at the point of use for up to one month.

• Health Canada announces new measures for use of neonicotinoid pesticide imidacloprid

  5/19/2021

  Health Canada released the final re-evaluation decision on the risk to human health and the environment from the neonicotinoid pesticide imidacloprid.

• Government of Canada supports safer supply project for people with opioid use disorder in Peterborough

  5/17/2021

  Life-saving initiative will provide pharmaceutical-grade medication as alternative to toxic illegal drug supply during COVID-19 pandemic and beyond

• Statement from the Chief Public Health Officer of Canada on May 13, 2021

  5/13/2021

  The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

• Advisory - When purchasing smoke or carbon monoxide alarms, look for a Canadian certification mark

  5/12/2021

  Uncertified smoke or carbon monoxide alarms may not meet Canadian performance standards and may fail to operate properly, posing a health or safety risk to Canadians.

• Government of Canada increases access to COVID-19 rapid testing for workers

  5/7/2021

  Increasing rapid antigen testing will help identify people not showing symptoms of infection who may be carrying COVID-19 into workplaces and communities

• Government of Canada Invests $3.1 Million to Expand Virtual Health Care Services in the Northwest Territories

  5/6/2021

  Canada's universal, publicly funded health care system is a source of pride for Canadians. The Government of Canada is working closely with provincial and territorial governments to strengthen health care and adapt the system to the challenges of delivering health care during the COVID-19 pandemic, and as we move into recovery.

• Government of Canada continues to take action to support people with chronic pain

  5/5/2021

  The Government of Canada recognizes the need to improve the health system's capacity to better understand, prevent and manage chronic pain.